| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/15/2011 | US7888390 Preparation of platinum(II) complexes |
| 02/15/2011 | US7888389 Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies |
| 02/15/2011 | US7888388 Peroxisome proliferator activated receptor ligand and process for producing the same |
| 02/15/2011 | US7888387 Electro-optic chromophore having an edot structure, and related methods and apparatuses |
| 02/15/2011 | US7888386 3-(phenoxyphenylmethyl)pyrrolidine compounds |
| 02/15/2011 | US7888385 Airway alkalinization as therapy for airway diseases |
| 02/15/2011 | US7888384 Heterocyclic derivatives for modulation of calcium channels |
| 02/15/2011 | US7888383 Organic compounds |
| 02/15/2011 | US7888380 1,2,4-Triazolylaminoaryl (heteroaryl) sulfonamide derivatives |
| 02/15/2011 | US7888379 Thiazole derivatives and use thereof |
| 02/15/2011 | US7888378 Thiadiazole compounds and uses thereof |
| 02/15/2011 | US7888377 Monocyclic and bicyclic himbacine derivatives useful as thrombin receptor antagonists |
| 02/15/2011 | US7888376 Cholesteryl ester transfer protein (CETP) inhibitors; atherosclerosis and cardiovascular diseases; N-(1-(5-chloropyridin-2-yl)-1-(3-fluoro-5-(trifluoromethyl)phenyl)-2-phenylethyl)-4-(trifluoromethyl)thiazol-2-amine; Alzheimer's, atherosclerosis, venous thrombosis, peripheral vascular disease |
| 02/15/2011 | US7888375 Pyridinone diketo acids: inhibitors of HIV replication |
| 02/15/2011 | US7888374 Inhibitors of c-jun N-terminal kinases |
| 02/15/2011 | US7888373 Heterocyclic sulfonamides as modulators of cardiac sarcomeres |
| 02/15/2011 | US7888372 Compositions and methods for modulating bone mineral deposition |
| 02/15/2011 | US7888371 Use of triazolopyrimidine derivatives as microbicides |
| 02/15/2011 | US7888370 Topical ophthalmic or otic solution formulations containing moxifloxacin hydrochloride and dexamethasone phosphate |
| 02/15/2011 | US7888369 Oxazoloisoquinoline derivatives as thrombin receptor antagonists |
| 02/15/2011 | US7888368 Treatment of drug-resistant tumors |
| 02/15/2011 | US7888367 reverse transcriptase mutants which allow an obligate chain terminating nucleoside- or nucleotide phosphate to be excised from the nascent DNA strand by ATP- or pyrophosphate-mediated excision |
| 02/15/2011 | US7888366 2,4-diaminoquinazolines for spinal muscular atrophy |
| 02/15/2011 | US7888365 1 and 3'-methyl-4-(2-phenylpropan-2-yl)biphenyl-2-ol; acute and chronic infectious and non-infectious inflammation, cancer, immuno-suppression, ischemic tissue injury |
| 02/15/2011 | US7888364 Pyridyl inhibitors of hedgehog signalling |
| 02/15/2011 | US7888363 1-Cyclopentyl-3-methyl-2-(2-pyridyl)indole-5-amino/thio/carbonyl derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 02/15/2011 | US7888362 Piperazine-substituted benzothiophenes for treatment of mental disorders |
| 02/15/2011 | US7888361 anticancer; inhibits both BCR-ABL and histone deacetylase activity; N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-(hydroxyamino)-2-oxoethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide |
| 02/15/2011 | US7888360 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 02/15/2011 | US7888359 Cyclohexyl or piperidinyl carboxamide antibiotic derivatives |
| 02/15/2011 | US7888358 Serotonine, dopamine and norendrenaline receptors; antidepressants, anxiolytic agents, eating disorders; obesity; bipolar; drug abuse; neurodegenerative diseases |
| 02/15/2011 | US7888357 Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death |
| 02/15/2011 | US7888356 Antibiotics containing borinic acid complexes and methods of use |
| 02/15/2011 | US7888355 Compositions and methods for inhibiting growth and metastasis of melanoma |
| 02/15/2011 | US7888354 Phenylpyrazole derivatives |
| 02/15/2011 | US7888353 Metabotropic glutamate receptor isoxazole ligands and their use as potentiators |
| 02/15/2011 | US7888352 1-(4-((2-(2-aminopyrimidin-5-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazin-1-yl)-2-(methylsulfonyl)ethanone; lipid kinase inhibitor; anticarcinogenic agent; |
| 02/15/2011 | US7888350 3,7-diamino-10H-phenothiazine salts and their use |
| 02/15/2011 | US7888349 Piperazine, [1,4]Diazepane, [1,4]Diazocane, and [1,5]Diazocane fused imidazo ring compounds |
| 02/15/2011 | US7888348 7-membered ring compound and method of production and pharmaceutical application thereof |
| 02/15/2011 | US7888347 Pyrazolo [3,4-D]azepine derivatives as histamine H3 antagonists |
| 02/15/2011 | US7888346 Method of treating organophosphorous poisoning |
| 02/15/2011 | US7888345 Benzaepinones as sodium channel blockers |
| 02/15/2011 | US7888344 Fused thiazole derivatives as kinase inhibitors |
| 02/15/2011 | US7888343 Substituted, bicyclic 8-pyrrolidinoxanthines, and methods for their use as inhibitors of dipeptidyl peptidase |
| 02/15/2011 | US7888342 Methods of treating fibromyalgia syndrome, chronic fatigue syndrome and pain |
| 02/15/2011 | US7888341 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide; antitumor; antiproliferative agent; synergistic therapy for resistant; Bcr/Abl, leukemia |
| 02/15/2011 | US7888339 2-methylene-20(21)-dehydro-19-nor-vitamin D analogs |
| 02/15/2011 | US7888338 7-(2-cyclohexylidene-ethylidene)-spiro[4.5]decanes |
| 02/15/2011 | US7888337 Synthesis of oseltamivir containing phosphonate congeners with anti-influenza activity |
| 02/15/2011 | US7888336 Indole compounds bearing aryl or heteroaryl groups having sphingosine 1-phosphate (S1P) receptor biological activity |
| 02/15/2011 | US7888335 Mitoquinone derivatives used as mitochondrially targeted antioxidants |
| 02/15/2011 | US7888334 lipophilic cationic moiety linked by to an antioxidant; a salt forming anion; does not exhibit reactivity against the lipophilic cationic moiety; Parkinson's, Alzheimer's disease, Huntington's Chorea and Friedreich's Ataxia |
| 02/15/2011 | US7888333 Targeted gene deletions for polysaccharide slime formers |
| 02/15/2011 | US7888332 Hydrazide-containing CFTR inhibitor compounds and uses thereof |
| 02/15/2011 | US7888331 Ganglioside compositions and methods of use |
| 02/15/2011 | US7888330 Phosphoramidate derivatives of FAU |
| 02/15/2011 | US7888329 Substituted aryl piperidinylalkynyladenosines as A2AR agonists |
| 02/15/2011 | US7888328 Oral formulations of cladribine |
| 02/15/2011 | US7888327 Methods of using immunostimulatory nucleic acid molecules to treat allergic conditions |
| 02/15/2011 | US7888325 Composition and method for in vivo and in vitro attenuation of gene expression using double stranded RNA |
| 02/15/2011 | US7888324 Antisense modulation of apolipoprotein B expression |
| 02/15/2011 | US7888320 Composition for treating cancer adapted for intra-tumoral administration and uses thereof |
| 02/15/2011 | US7888311 for decontaminating soils and water; for detecting and treating people contaminated by uranium |
| 02/15/2011 | US7888310 Analyzing plasma/urine for concentrations of norepinephrine, dopamine, serotonin, or fasting triglycerides or their metabolitess or dopamine or its metabolites or fasting triglycerides and/or blood pressure; pretreatment of metabolic disorders; administering bromocriptine; side effect reduction |
| 02/15/2011 | US7888114 encoding a Herpesviridae thymidine kinase enzyme comprising one or more mutations; for gene therapy, cancer |
| 02/15/2011 | US7888091 Fusion proteins having thymidine kinase and guanylate kinase activities |
| 02/15/2011 | US7888029 Eubacterial tmRNA sequences and uses thereof |
| 02/15/2011 | US7888028 Eubacterial tmRNA sequences and uses thereof |
| 02/15/2011 | US7887926 Triblock polymers and polymer coatings |
| 02/15/2011 | US7887868 low-salt soy sauce having an antihypertensive effect; contains 3.55% or less by weight of sodium, 0.5% to 3.6% by weight of potassium, 0.05 to 20% by weight of at least one polyphenol |
| 02/15/2011 | US7887860 Anti-bacterial plant compositions |
| 02/15/2011 | US7887859 Methods of treating epiphora |
| 02/15/2011 | US7887852 Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols |
| 02/15/2011 | US7887848 contains chromium, zinc, berry extract comprising anthocyanins, Polygonum cuspidatum extract, trans-resveratrol, 1-arginin, chlorophyllin |
| 02/15/2011 | US7887847 promotes visual health and reduces or reverses visual acuity loss by reduced Vitamin E with addition of taurine, omega-3 fatty acids, and non proform Vitamin A carotenoids including lutein and zeaxanthin |
| 02/15/2011 | US7887845 Antiviral compositions |
| 02/15/2011 | US7887844 Multiparticulate crystalline drug compositions having controlled release profiles |
| 02/15/2011 | US7887841 Multilayer, drug core, delay release gum compression coatings |
| 02/15/2011 | US7887840 Bioavailability of low- solubility drugs |
| 02/15/2011 | US7887836 involve the administration of liposome-encapsulated vinca alkaloids; liposome comprises sphingomyelin, cholesterol and vincristine ; for lymphoma, leukemia and myeloma in a human; non-Hodgkin's Lymphomas |
| 02/15/2011 | US7887833 Amphiphilic compounds and vesicles liposomes for organ-specified drug targeting |
| 02/15/2011 | US7887831 comprising synthetic apatite and supplementary bioactive agent such as biocompatible polysaccharide and anti-resorptive agent added ab initio; for treating orthopedic, periodontal and craniofacial indications |
| 02/15/2011 | US7887823 Oat extracts: refining, compositions and methods of use |
| 02/15/2011 | US7887817 Process for preventing protozoal diseases |
| 02/15/2011 | US7887806 Mammalian receptor proteins DCRS5; method of treatment |
| 02/15/2011 | US7887796 for a disorder of a subject's heart involving loss of cardiomyocytes by administering an amount of an agent effective to cause cardiomyocyte proliferation within the subject's heart; Vitamin D3 Up-Regulated Protein-1 |
| 02/15/2011 | US7887795 processing adipose tissue to deliver a concentrated amount of stem cells obtained from the adipose tissue to a patient; making an enhanced, autologous fat graft comprising supplementing a first portion of extracted adipose tissue with an additive and a disaggregated population of adipose-derived cells |
| 02/15/2011 | US7887790 Polymers and polymer coatings |
| 02/15/2011 | US7887789 Water soluble polymer such as polyethylene glycol containing a urethane linkage and reactive group for conjugating with biodrugs |
| 02/15/2011 | US7887784 Potent and selective binding affinity for the norpeinephrine transporter (NET) protein found in peripheral and central nervous system tissues |
| 02/15/2011 | CA2689052C Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 02/15/2011 | CA2633083C Sulfoximine derivatives as p38 map kinase inhibitors |
| 02/15/2011 | CA2628883C Novel 3'-modified oligonucleotide derivatives |
| 02/15/2011 | CA2626402C Potassium channel inhibitors |
| 02/15/2011 | CA2624949C Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf.alpha. levels |
| 02/15/2011 | CA2617000C Methods for preparing nevirapine hemihydrate and an aqueous suspension thereof |
| 02/15/2011 | CA2615271C Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts |
| 02/15/2011 | CA2592986C Heteroaromatic quinoline compounds |
| 02/15/2011 | CA2558272C Pyridone derivative |